Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiao-Xia Niu

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Hepatology (Baltimore, Md.)|January 31, 2022
ReplyYa Deng, Chun-Yan Wang, Xiao-Xia Niu, et al.
Hepatology (Baltimore, Md.)|February 3, 2022
ReplyXiao-Xia Niu, Ya Deng, Chun-Yan Wang, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|June 9, 2004
[Expression, purification and identification of recombinant human lymphotoxin alpha deletant (rhLT-alphaDeltaN27)]Yong-quan Liu, Dao-feng Li, Xiao-xia Niu, et al.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|May 1, 2013
[Development and evaluation of a quantitative double antibodies sandwich ELISA assay for rIFN-alpha1b]Mei-Ying Wu, Yan-Ping Ai, Yan Cao, et al.
European Journal of Gastroenterology & Hepatology|February 20, 2025
Leveraging the gut microbiome to understand the risk factor of cognitive impairment in patients with liver cirrhosisShuyao Li, Xiao-Xia Niu, Jia-Liang Liu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2021
Switching from entecavir to tenofovir alafenamide for chronic hepatitis B patients with low-level viraemiaZhong-Bin Li, Le Li, Xiao-Xia Niu, et al.
Frontiers in Pharmacology|March 6, 2023
Autoimmunity associates with severity of illness in elderly patients with drug-induced liver injuryYu-Ting Xiong, Jian-Fei Wang, Xiao-Xia Niu, et al.
Metabolism Open|April 23, 2021
Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up studyDong Ji, Guo-Feng Chen, Xiao-Xia Niu, et al.
ILIVER|July 10, 2025
Metabolic syndrome is associated with significant hepatic fibrosis and steatosis in patients with nonalcoholic steatohepatitisQian-Qian Li, Yu-Ting Xiong, Danni Wang, et al.
Frontiers in Pharmacology|September 6, 2021
The LAC Score Indicates Significant Fibrosis in Patients With Chronic Drug-Induced Liver Injury: A Large Biopsy-Based StudyZhong-Bin Li, Dan-Dan Chen, Qing-Juan He, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Hepatology (Baltimore, Md.)|January 31, 2022
ReplyYa Deng, Chun-Yan Wang, Xiao-Xia Niu, et al.
Hepatology (Baltimore, Md.)|February 3, 2022
ReplyXiao-Xia Niu, Ya Deng, Chun-Yan Wang, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|June 9, 2004
[Expression, purification and identification of recombinant human lymphotoxin alpha deletant (rhLT-alphaDeltaN27)]Yong-quan Liu, Dao-feng Li, Xiao-xia Niu, et al.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|May 1, 2013
[Development and evaluation of a quantitative double antibodies sandwich ELISA assay for rIFN-alpha1b]Mei-Ying Wu, Yan-Ping Ai, Yan Cao, et al.
European Journal of Gastroenterology & Hepatology|February 20, 2025
Leveraging the gut microbiome to understand the risk factor of cognitive impairment in patients with liver cirrhosisShuyao Li, Xiao-Xia Niu, Jia-Liang Liu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2021
Switching from entecavir to tenofovir alafenamide for chronic hepatitis B patients with low-level viraemiaZhong-Bin Li, Le Li, Xiao-Xia Niu, et al.
Frontiers in Pharmacology|March 6, 2023
Autoimmunity associates with severity of illness in elderly patients with drug-induced liver injuryYu-Ting Xiong, Jian-Fei Wang, Xiao-Xia Niu, et al.
Metabolism Open|April 23, 2021
Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up studyDong Ji, Guo-Feng Chen, Xiao-Xia Niu, et al.
ILIVER|July 10, 2025
Metabolic syndrome is associated with significant hepatic fibrosis and steatosis in patients with nonalcoholic steatohepatitisQian-Qian Li, Yu-Ting Xiong, Danni Wang, et al.
Frontiers in Pharmacology|September 6, 2021
The LAC Score Indicates Significant Fibrosis in Patients With Chronic Drug-Induced Liver Injury: A Large Biopsy-Based StudyZhong-Bin Li, Dan-Dan Chen, Qing-Juan He, et al.
Pageof 2